EIF4E and malignant colon neoplasm: GSK3 can mediate phosphorylation of RBM38 at serine 195, causing RBM38 conformation to change, which prevents it from binding to eukaryotic translation initiation factor 4E (eIF4E) on p53 mRNA in breast and colon cancer cells [87–89].